Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,386.50
(
0.49%
)
News Focus
News Focus
Post# of 446517
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Jimmy Joe

Send PM Follow Ignore
Followers 124
Posts 21771
Boards Moderated 0
Alias Born 08/27/2005

Jimmy Joe

Re: Chasing post# 299088

Sunday, 08/26/2018 11:38:36 AM

Sunday, August 26, 2018 11:38:36 AM

Post# of 446517
The important thing to remember here is: has Elite addressed the CRL issue? Yes Elite has addressed this issue.

NH said after the first reformulation attempt that Elite would attempt to reformulate again. IF the reformulation was successful Elite would go on with SequestOx. Pilot study shows that the reformulation was indeed successful. Elite is going forward with SequestOx. Pilot study submitted to the FDA. Elite awaits a response back.


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ELTP News
More ELTP News